Key Performance
More- Earnings Score: N/A
- Momentum Score: 15
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
The Gross Law Firm has initiated a class action lawsuit against Nano-X Imaging Ltd. (NNOX) on behalf of shareholders who purchased shares between March 31, 2025 and April 17, 2026. The complaint alleges that the company issued materially false and misleading statements regarding operational efficiency gains and product demand, while concealing poor alignment between production and actual demand, increased operating expenses, and significant cash burn that would necessitate disruptive restructuring measures.
06/19/2026, 10:25 AM • GlobeNewswire
Class action lawsuits have been filed against BitGo Holdings, Erasca, Nano-X Imaging, and Microsoft Corporation, alleging that defendants made materially false and misleading statements and failed to disclose material adverse facts about their businesses. Investors have until August 7-11, 2026 to file lead plaintiff motions.
06/18/2026, 12:53 PM • GlobeNewswire
Rosen Law Firm has filed a class action lawsuit against Nano-X Imaging Ltd. (NNOX) on behalf of investors who purchased securities between March 31, 2025 and April 17, 2026. The lawsuit alleges that defendants made false and misleading statements regarding operational efficiency gains and product demand, while concealing poor alignment between production and demand, increased operating expenses, and significant cash burn that necessitated restructuring measures.
06/16/2026, 10:28 PM • GlobeNewswire
A class action lawsuit has been filed against Nano-X Imaging Ltd. for allegedly making false and misleading statements about operational efficiency and product demand during the period from March 31, 2025 to April 17, 2026. The lawsuit claims the company overstated efficiency gains while concealing poor alignment between production and demand, leading to increased operating expenses and cash burn. On April 20, 2026, Nano-X reported a $33.4 million net loss including a $17.5 million impairment charge related to restructuring at its Korean manufacturing facility, causing the stock to decline 25% from $2.85 to $2.15 per share.
06/15/2026, 5:34 PM • GlobeNewswire
A class action lawsuit has been filed against Nano-X Imaging Ltd. alleging that company executives made materially false and misleading statements regarding operational efficiency and product demand. The complaint claims Nano-X overstated efficiency gains while concealing poor alignment between production and demand, leading to increased operating expenses and cash burn. Investors who purchased securities between March 31, 2025 and April 17, 2026 may be eligible to join the case.
06/15/2026, 1:00 PM • GlobeNewswire
NNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.
Law firm Kirby McInerney LLP is investigating Nano-X Imaging Ltd. for potential federal securities law violations following the company's announcement of a $33.4 million net loss in Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The announcement triggered a 25% stock price decline from $2.85 to $2.15 per share on April 20, 2026, and prompted CFO Ran Daniel's resignation effective July 31, 2026.
05/05/2026, 6:00 PM • GlobeNewswire
Pomerantz LLP is investigating potential securities fraud claims against Nano-X Imaging Ltd. following the company's announcement of a $33.4 million net loss for Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The announcement triggered a 24.39% stock price decline. The company's CFO is also stepping down effective July 31, 2026.
04/28/2026, 5:40 PM • GlobeNewswire
Kirby McInerney LLP is investigating Nano-X Imaging Ltd. for potential securities law violations following the company's announcement of a $33.4 million net loss in Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The announcement triggered a 25% stock price decline from $2.85 to $2.15 per share on April 20, 2026, and prompted CFO Ran Daniel's resignation effective July 31, 2026.
04/27/2026, 8:22 PM • GlobeNewswire
The Schall Law Firm has launched a fraud investigation into Nano-X Imaging Ltd. (NNOX) on behalf of investors, examining whether the company issued false or misleading statements. Nano-X reported a $17.5 million impairment charge related to its Korean chip manufacturing facility in Q4 2025 and announced its CFO's departure in July, triggering a 25% stock price decline.
04/26/2026, 10:30 PM • GlobeNewswire
Law firm Bragar Eagel & Squire is investigating Nano-X Imaging Ltd. for potential federal securities law violations following the company's announcement of a $33.4 million net loss in Q4 2025, including a $17.5 million asset impairment charge related to its Korean chip manufacturing facility restructuring. The news triggered a 25% stock price decline from $2.85 to $2.15 per share on April 20, 2026, and prompted CFO Ran Daniel's resignation effective July 31, 2026.
04/23/2026, 5:40 PM • GlobeNewswire
Nanox Announces $15 Million Registered Direct Offering of Common Stock
Nanox has entered into a securities purchase agreement with an institutional investor to sell 3,826,530 ordinary shares, expecting to raise approximately $15 million for working capital and corporate growth initiatives.
11/23/2025, 11:26 PM • GlobeNewswire
Nanox is collaborating with Monarch Medical Management to deploy advanced medical imaging solutions across workers' compensation, nursing homes, and outpatient clinics, with plans to establish a comprehensive imaging network nationwide.
09/18/2025, 8:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/23/2026
Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.